ARTA
AERI

A.R.T. Advisors’s Aerie Pharmaceuticals AERI Stock Holding History

A.R.T. Advisors’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-56,275
Closed -$1.66M – 1825
2019
Q2 		$1.66M Buy
56,275
+44,300
+370% +$1.71M 0.09% 285
2019
Q1 		$569K Buy
11,975
+838
+8% +$36.9K 0.03% 703
2018
Q4 		$402K Buy
+11,137
New +$522K 0.03% 812
2017
Q3 		– Sell
-13,400
Closed -$704K – 1773
2017
Q2 		$704K Sell
13,400
-22,100
-62% -$1.03M 0.04% 656
2017
Q1 		$1.61M Buy
+35,500
New +$1.58M 0.07% 389
2016
Q4 		– Sell
-7,900
Closed -$298K – 1436
2016
Q3 		$298K Sell
7,900
-28,967
-79% -$639K 0.1% 350
2016
Q2 		$648K Sell
36,867
-135,165
-79% -$2.19M 0.03% 708
2016
Q1 		$2.09M Buy
172,032
+96,145
+127% +$1.52M 0.09% 315
2015
Q4 		$1.85M Buy
+75,887
New +$1.77M 0.09% 321
2015
Q3 		– Sell
-169,438
Closed -$2.99M – 1677
2015
Q2 		$2.99M Buy
+169,438
New +$3.11M 0.1% 303
2015
Q1 		– Sell
-19,226
Closed -$561K – 1771
2014
Q4 		$561K Buy
+19,226
New +$488K 0.02% 884

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

A.R.T. Advisors's AERI Position: Q3 2019 in Review

A.R.T. Advisors sold out of Aerie Pharmaceuticals (AERI) in Q3 2019, closing a stake of 56,275 shares — an estimated $1.66M sold.

A.R.T. Advisors first reported a position in AERI in Q4 2014 and held it in 11 quarters. The position peaked at $2.99M in Q2 2015. 167 funds tracked by Wall St. Rank hold AERI as of Q3 2019.

  • A.R.T. Advisors reported no remaining Aerie Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 56,275 Aerie Pharmaceuticals shares in Q3 2019, an estimated $1.66M.
  • A.R.T. Advisors first reported a position in Aerie Pharmaceuticals in Q4 2014 and held it in 11 quarters.
  • A.R.T. Advisors's Aerie Pharmaceuticals position peaked at $2.99M in Q2 2015.
  • 167 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2019.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.